Atherosclerosis: Inflammatory disease!;L'athérosclérose : Une maladie inflammatoire!

Medecine et Hygiene

Volumn 58, Issue 2292, 2000, Pages 617-623

  Mach, F ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0009950818     PISSN: 00256749     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Murray CJ, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: Global burden of disease study. Lancet 1997; 349: 1498-504.
2. Stary HC. Evolution and progression of atherosclerotic lesions in coronary arteries of children and young adults. Arteriosclerosis 1989; 9: (Suppl. 1): 19-32.
3. Libby P. Molecular basis of acute coronary syndromes. Circulation 1995; 91: 2844-50.
4. Ross R. Atherosclerosis: An inflammatory disease. N Engl J Med 1999; 340: 115-26.
5. Boring L, Gosling J, Cleary M, Charo IF. Decreased lesion formation in CCR2-/- mice reveals a role for chemokines in the initiation of atherosclerosis. Nature 1998; 394: 894-7.
6. Mach F, Schönbeck U, Sukhova GK, Atkinson E, Libby P. Reduction of CD40 signalling. Nature 1998; 394: 200-3.
7. Stemme S, Huhn J, Hansson GK. T lymphocytes in human atherosclerotic plaques are memory cells expressing CF45RO and the integrin VLA-1. Arterioscler Thromb 1992; 12: 206-11.
8. Stemme S, Hansson GK. Immune mechanisms in atherogenesis. Ann Medicine 1994; 26: 141-6.
9. Steinberg D, Witzum JL. Lipoproteins and atherogenesis. Current concepts. JAMA 1990; 264: 3047-52.
10. Ross R. The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 1993; 362: 801-9.
11. Falk E, Shah PK, Fuster V. Coronary plaque disruption. Circulation 1995; 92: 657-71.
12. Zambon A, Hokanson JE, Brown BG, Brunzell JD. Evidence for a new pathophysiological mechanism for coronary artery regression: Hepatic lipase-mediated changes in LDL density. Circulation 1999; 99: 1959-64.
13. Moreno PR, Falk E, Palacios IF, Newell JB, Fuster V, Fallon JT. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994; 90: 775-8
14. Swanson SJ, Rosenzweig A, Seidman JG, Libby P, Diversity of T-cell antigen receptor V beta gene utilization in advanced human atheroma. Arteioscler Thromb 1994; 14: 1210-14.
15. Ridler PM. Novel risk factors and markers for coronary disease. Adv Intern Med 2000; 45: 391-418.
16. Terkelataub R, Boisvert WA, Curtiss LK. Chemokines and atherosclerosis. Curr Opin Lipidol 1998; 9: 397-405.
17. Luster AD. Chemokines: Chemotactic cytokines that mediate inflammation. N Engl J Med 1998; 338: 436-45.
18. Baggiolini M. Chemokines and leukocyte traffic. Nature 1998; 392: 565-8.
19. Mach F, Saury A, Iarossi A, Sukhova GK, Neote K, Libby P, Luster AD. Differential expression of the three T lymphocyte-activating CXC chemokines by human atheroma-associated cells. J Clin Invest 1999; 104: 1041-50.
20. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q. Is atherosclerosis an immunologically mediated disease? Immunol Today 1995; 16: 27-33.
21. Amento EP, Ehsani N, Palmer H, Libby P. Cytokines and growth factors positively and negatively regulate interstitial collagen gene expression in human vascular smooth muscle cells. Arterioscler Thromb 1991; 11: 1223-30.
22. Mach F, Schönbeck U, Bonnefoy J-Y, Pober JS, Libby P. Activation of monocyte/macrophage function related to acute atheroma complication by ligation of CD40. Circulation 1997; 96: 396-9.